Articles with "laherparepvec melanoma" as a keyword



Photo from wikipedia

Clinical experience with talimogene laherparepvec in a melanoma population at a university based cancer center.

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2018.36.15_suppl.e21547

Abstract: e21547Background: Talimogene laherparepvec (Imlygic or T-VEC) is a first-in-class oncolytic virus that received FDA approval for recurrent unresectable melanoma based on the OPTiM trial. Since its ... read more here.

Keywords: talimogene laherparepvec; experience talimogene; talimogene; clinical experience ... See more keywords